Navigation Links
Bradmer in Medical News

Notice of Bradmer Pharmaceuticals Conference Call

TSX: BMR TORONTO, March 5 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, will release its year end fiscal results for 2007 on March 12, 2008, at 7:00 AM E...

Bradmer to repurchase up to 8.3 million of its common shares pursuant to a substantial issuer bid

...BMR TORONTO, July 17 /PRNewswire-FirstCall/ - bradmer Pharmaceuticals Inc. (TSX: BMR) ("Bradmer" or the ... fees and expenses of the Offer, will be funded by bradmer out of cash on hand. "While we continue to pursu...e existing cash on hand will be utilized to ensure bradmer is left with no future obligations or liabilities....

Bradmer announces 2009 first quarter operational and financial results

...: BMR TORONTO, May 7 /PRNewswire-FirstCall/ - bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") ...AAP). For the three months ended March 31, 2009, bradmer recorded a net loss of $2,192,000 or $0.16 per com...ntly lower interest rates. As at March 31, 2009, bradmer had available cash of $5,982,000 as compared to ca...

Bradmer announces 2008 fourth quarter and fiscal year operational and financial results

...MR TORONTO, March 31 /PRNewswire-FirstCall/ - bradmer Pharmaceuticals Inc. ("Bradmer" or the "Corporatio...ian GAAP). For the year ended December 31, 2008, bradmer recorded a net loss of $11,529,000 or $0.85 per co...2008, compared to $2,620,000 in 2007. During 2007, bradmer manufactured drug product and conducted considerab...

Bradmer implements cash conservation plan

...MR TORONTO, March 5 /PRNewswire-FirstCall/ - bradmer Pharmaceuticals Inc. (BMR.TSX), today announced th...hile the strategic evaluation process is underway, bradmer has suspended patient enrollment in the GLASS-ART ...ve Officer of Bradmer. "The major cost drivers for bradmer are clinical operations support, patient enrollmen...

Bradmer provides clinical trial update and announces evaluation of strategic alternatives

...BMR TORONTO, Feb. 17 /PRNewswire-FirstCall/ - bradmer Pharmaceuticals Inc. (BMR.TSX), provided an update...most advanced form of brain cancer (glioblastoma). bradmer also announced that its Board of Directors has rec...with regulatory and budgeting processes completed. bradmer has now also completed a review of the first cohor...

Bradmer to participate in panel presentation at RBC Capital Markets Healthcare Conference

... TORONTO, Dec. 9 /PRNewswire-FirstCall/ - bradmer Pharmaceuticals Inc., a biopharmaceutical company ...n, Ph.D., President and Chief Executive Officer of bradmer will be presenting as a panel participant at the 2...e for 30 days after the conference. About bradmer Pharmaceuticals Inc. ( www.bradmerpharma.com ) ...

Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting

... TORONTO, Nov. 19 /PRNewswire-FirstCall/ - bradmer Pharmaceuticals Inc., a biopharmaceutical company ...but absent from normal brain cells. About bradmer Pharmaceuticals Inc. ( www.bradmerpharma.com ) bradmer Pharmaceuticals is a biopharmaceutical company foc...

Bradmer announces 2008 third quarter operational and financial results

...X: BMR TORONTO, Nov. 10 /PRNewswire-FirstCall/ - bradmer Pharmaceuticals Inc., a clinical oncology company ...arch organizations of $745,000. During the period, bradmer expanded drug manufacturing analytical support and...es over the past year. As at September 30, 2008, bradmer had available cash and cash equivalents and short-...

Bradmer to present at Rodman & Renshaw Healthcare Conference

...SX: BMR TORONTO, Nov. 3 /PRNewswire-FirstCall/ - bradmer Pharmaceuticals Inc., a biopharmaceutical company ... cells but absent from normal brain cells. About bradmer Pharmaceuticals Inc. (http://www.bradmerpharma.com ) bradmer Pharmaceuticals is a biopharmaceutical company foc...
Bradmer in Medical Technology

Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials

...X: BMR TORONTO, July 17 /PRNewswire-FirstCall/ - bradmer Pharmaceuticals Inc. (TSX: BMR), a biopharmaceutic... months in 19 GBM patients treated with Neuradiab. bradmer is currently conducting a Phase III clinical trial...and Drug Administration (FDA) which suggested that bradmer may opt to evaluate sensitivities around the merit...

Molecular Target of Bradmer's Neuradiab Further Validated by Independent Findings

... of internal radiation directly to tumor cells." bradmer is preparing to initiate a proposed multicenter Ph...Food and Drug Administration regulatory approvals, bradmer plans to begin its multicenter clinical trial of N... cells but absent from normal brain cells. About bradmer Pharmaceuticals Inc. (
(Date:10/25/2014)... Randy Dotinga HealthDay Reporter ... more genetic tests are developed that spot increased risks for ... more proactive about getting screened. But a new study ... change behavior: People who found out their genes doubled their ... with average risk to get screened. "It didn,t make ...
(Date:10/22/2014)... On October 22, CBS will air ... diseases both fictional and real. The Charles E ... committed to advocacy and philanthropy in the battle against ... opportunity to impart truth and clarity about this misunderstood ... many misconceptions about Morgellons Disease (MD) and ...
(Date:10/22/2014)... Amy Norton HealthDay ... Headlines remain riveted on the three Ebola cases in Dallas. ... bigger health threat to Americans. President Barack Obama on ... to the virus, which has infected two Dallas nurses who ... month at Texas Health Presbyterian Hospital. But the U.S. ...
(Date:10/22/2014)... 2014 Hay House is pleased to announce ... Upgrade Your Life (Paperback; $10.82) written by the highly esteemed ... This book is meant to help readers of all ... recovery. , Recovery 2.0 is not the average self-help ... is a guide for what comes next. For ...
Breaking Medicine News(10 mins):Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3
(Date:10/18/2014)... sample of patients with undiagnosed, suspected genetic conditions, a ... a higher molecular diagnostic yield than traditional molecular diagnostic ... . The study is being released to coincide with ... Exome sequencing, which sequences the protein­coding region of the ... present in a cell or organism), has been rapidly ...
(Date:10/17/2014)... the University of Copenhagen have shown for the first ... of Cystic fibrosis patients, giving them the opportunity to ... chronic infections. , The study also discovered the bacterial ... patients was halted or slowed down by the immune ... the oxygen and helped "suffocate" the bacteria, forcing the ...
(Date:10/16/2014)... Researchers at William and Mary,s Virginia Institute of ... from the Environmental Protection Agency to identify the ... and to develop tools to help local governments ... project depends critically on a dataset of tidal-marsh ... 1970s. Only with this historical baseline can today,s ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3
Other Contents